Impact of insurance status on overall survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS-HIPEC)

OBJECTIVES: The impact of insurance status on oncological outcome in patients undergoing cytoreduction and hyperthermic intraperitoneal chemotherapy (CRS-HIPEC) is poorly understood. METHODS: Retrospective study on 31 patients having undergone 36 CRS-HIPEC at a single institution (safety-net hospita...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Pleura Peritoneum
Glavni autori: Chokshi, Ravi J., Kim, Jin K., Patel, Jimmy, Oliver, Joseph B., Mahmoud, Omar
Format: Artigo
Jezik:Inglês
Izdano: De Gruyter 2020
Teme:
Research Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7746885/
https://ncbi.nlm.nih.gov/pubmed/33364338
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1515/pp-2020-0105
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items